A detailed history of Voya Investment Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 90,345 shares of BMRN stock, worth $6.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
90,345
Previous 89,467 0.98%
Holding current value
$6.02 Million
Previous $7.37 Million 13.78%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$69.02 - $93.84 $60,599 - $82,391
878 Added 0.98%
90,345 $6.35 Million
Q2 2024

Dec 03, 2024

SELL
$74.43 - $92.22 $65,349 - $80,969
-878 Reduced 0.97%
89,467 $7.37 Million
Q2 2024

Aug 14, 2024

BUY
$74.43 - $92.22 $337,465 - $418,125
4,534 Added 5.34%
89,467 $7.37 Million
Q1 2024

Dec 06, 2024

SELL
$83.81 - $99.0 $453,579 - $535,788
-5,412 Reduced 5.99%
84,933 $7.42 Million
Q1 2024

May 15, 2024

SELL
$83.81 - $99.0 $656,148 - $775,071
-7,829 Reduced 8.44%
84,933 $7.42 Million
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $355,337 - $459,253
4,662 Added 5.29%
92,762 $8.94 Million
Q3 2023

Nov 14, 2023

SELL
$85.07 - $94.48 $37,600 - $41,760
-442 Reduced 0.5%
88,100 $7.8 Million
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $629,383 - $728,278
7,261 Added 8.93%
88,542 $7.67 Million
Q1 2023

May 15, 2023

BUY
$87.74 - $117.27 $402,200 - $537,565
4,584 Added 5.98%
81,281 $7.9 Million
Q4 2022

Feb 14, 2023

BUY
$80.93 - $108.63 $299,845 - $402,474
3,705 Added 5.08%
76,697 $7.94 Million
Q3 2022

Mar 03, 2023

SELL
$82.16 - $96.94 $304,402 - $359,162
-3,705 Reduced 4.83%
72,992 $6.19 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $4 Million - $4.72 Million
48,645 Added 199.8%
72,992 $6.19 Million
Q2 2022

Aug 15, 2022

SELL
$71.48 - $86.85 $88,992 - $108,128
-1,245 Reduced 4.86%
24,347 $2.02 Million
Q4 2021

Feb 14, 2022

SELL
$71.72 - $91.47 $241,624 - $308,162
-3,369 Reduced 11.63%
25,592 $2.26 Million
Q3 2021

Nov 15, 2021

SELL
$74.77 - $85.47 $9,421 - $10,769
-126 Reduced 0.43%
28,961 $2.24 Million
Q2 2021

Aug 16, 2021

SELL
$75.51 - $84.79 $2.08 Million - $2.34 Million
-27,560 Reduced 48.65%
29,087 $2.43 Million
Q1 2021

May 17, 2021

SELL
$74.73 - $90.69 $43.1 Million - $52.3 Million
-576,153 Reduced 91.05%
56,647 $4.28 Million
Q4 2020

Feb 16, 2021

BUY
$72.61 - $90.2 $2.08 Million - $2.59 Million
28,662 Added 4.74%
632,800 $55.5 Million
Q3 2020

Nov 16, 2020

SELL
$71.87 - $131.03 $46.6 Million - $84.9 Million
-647,917 Reduced 51.75%
604,138 $46 Million
Q2 2020

Aug 14, 2020

BUY
$79.55 - $124.22 $31.6 Million - $49.3 Million
397,054 Added 46.44%
1,252,055 $154 Million
Q1 2020

May 15, 2020

SELL
$71.37 - $96.85 $7.16 Million - $9.71 Million
-100,274 Reduced 10.5%
855,001 $72.2 Million
Q4 2019

Feb 14, 2020

BUY
$64.27 - $86.37 $10.2 Million - $13.7 Million
159,125 Added 19.99%
955,275 $80.8 Million
Q3 2019

Nov 14, 2019

SELL
$67.4 - $85.11 $1.87 Million - $2.36 Million
-27,672 Reduced 3.36%
796,150 $53.7 Million
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $1.57 Million - $1.84 Million
19,570 Added 2.43%
823,822 $70.6 Million
Q1 2019

May 15, 2019

SELL
$84.2 - $98.62 $2.36 Million - $2.77 Million
-28,073 Reduced 3.37%
804,252 $71.4 Million
Q4 2018

Feb 14, 2019

BUY
$80.14 - $106.07 $36.5 Million - $48.3 Million
455,754 Added 121.03%
832,325 $70.9 Million
Q3 2018

Nov 14, 2018

BUY
$93.92 - $105.72 $3.43 Million - $3.86 Million
36,494 Added 10.73%
376,571 $36.5 Million
Q2 2018

Aug 14, 2018

SELL
$76.01 - $99.03 $1.2 Million - $1.57 Million
-15,825 Reduced 4.45%
340,077 $32 Million
Q1 2018

May 15, 2018

SELL
$77.67 - $92.63 $31 Million - $37 Million
-399,609 Reduced 52.89%
355,902 $28.9 Million
Q4 2017

Feb 14, 2018

SELL
$80.76 - $95.13 $3.3 Million - $3.89 Million
-40,912 Reduced 5.14%
755,511 $67.4 Million
Q3 2017

Nov 14, 2017

BUY
$80.6 - $94.95 $64.2 Million - $75.6 Million
796,423
796,423 $74.1 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.